ARRAY BIOPHARMA INC 3 SEC Filings

Filed On	Filing
17 Aug 2018	Form 3: Cox Carrie Smith, Director No securities owned
17 Aug 2017	Form 3: Oltmans Curtis Gale, General Counsel
01 May 2017	Form 3: Sharp Shalini, Director
29 Jul 2016	Form 3: Haddock Jason, CFO
10 Sep 2015	Form 3: Henahan Mary P., Chief Financial Officer
10 Aug 2015	Form 3: Redmile Group, Llc, 10% owner and 1 other Holds 14,829,117 shares of Common stock, $0.001 par value
09 Feb 2015	Form 3: Horin David J, Interim CFO No securities owned
24 Sep 2014	Form 3: Sandor Victor, Chief Medical Officer
01 Aug 2014	Form 3: Array Biopharma Inc, 10% owner · Loxo Oncology, Inc.
03 Jul 2014	Form 3: Bvf Partners L P/IL, 10% owner and 5 others Holds 3,403,562 shares of Common Stock, $0.001 par value
03 Jun 2014	Form 3: Saccomano Nicholas A, CSO
28 Apr 2014	Form 3: Baum Charles M, Director
30 Oct 2013	Form 3: Robbins Andrews R, SVP, Commercial Operations
01 Apr 2013	Form 3: Needle Michael N, CMO
19 Nov 2012	Form 3: Bvf Partners L P/IL, 10% owner and 5 others Holds 790,501 shares of Common Stock, $0.001 par value
07 Nov 2012	Form 3: Orwin John A, Director
30 Apr 2012	Form 3: Squarer Ron, Director
30 Apr 2012	Form 3: Ratcliffe Liam, Director Holds 3,239,200 shares of Common Stock
06 Feb 2012	Form 3: Fyfe Gwen A., Director No securities owned
04 Nov 2011	Form 3: Bvf Partners L P/IL, 10% owner and 5 others Holds 1,674,216 shares of Common Stock of $0.001 par value

Comments